CFA
MLAB icon

Carroll Financial Associates’s Mesa Laboratories MLAB Stock Holding History

Carroll Financial Associates’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed -$1K – 1814
2021
Q3 		$1K Buy
+6
New +$1.71K ﹤0.01% 1670

Other funds holding MLAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Carroll Financial Associates's MLAB Position: Q4 2021 in Review

Carroll Financial Associates sold out of Mesa Laboratories (MLAB) in Q4 2021, closing a stake of 6 shares — an estimated $1K sold.

Carroll Financial Associates first reported a position in MLAB in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 178 funds tracked by Wall St. Rank hold MLAB as of Q4 2021.

  • Carroll Financial Associates reported no remaining Mesa Laboratories position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 6 Mesa Laboratories shares in Q4 2021, an estimated $1K.
  • Carroll Financial Associates first reported a position in Mesa Laboratories in Q3 2021 and held it in 1 quarter.
  • Carroll Financial Associates's Mesa Laboratories position peaked at $1K in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.